Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Sofosbuvir / Velpatasvir

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 650Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Gilead Sciences International Ltd

    02 4Gilead Sciences Ireland Uc

    03 1Gilead Sciences Switzerland S?rl

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Gilead Sciences International Ltd

    U.S.A
    OTS 2025
    Not Confirmed
    arrow

    Gilead Sciences International Ltd

    U.S.A
    arrow
    OTS 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Sofosbuvir / velpatasvir

    Brand Name : Epclusa

    Dosage Form : Antic-calc Tablet, Film Coated

    Dosage Strength : 400 mg/100 mg

    Packaging : Bottle

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Gilead Sciences Ireland Uc

    U.S.A
    OTS 2025
    Not Confirmed
    arrow

    Gilead Sciences Ireland Uc

    U.S.A
    arrow
    OTS 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Sofosbuvir Velpatasvir

    Brand Name : Epclusa

    Dosage Form : Coated Granule In Sachet

    Dosage Strength : 150mg/37.5mg

    Packaging :

    Approval Date : 10/01/2022

    Application Number : 20210209000020

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Gilead Sciences Ireland Uc

    U.S.A
    OTS 2025
    Not Confirmed
    arrow

    Gilead Sciences Ireland Uc

    U.S.A
    arrow
    OTS 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Sofosbuvir Velpatasvir

    Brand Name : Epclusa

    Dosage Form : Coated Granule In Sachet

    Dosage Strength : 200mg/50mg

    Packaging :

    Approval Date : 10/01/2022

    Application Number : 20210209000037

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Gilead Sciences Ireland Uc

    U.S.A
    OTS 2025
    Not Confirmed
    arrow

    Gilead Sciences Ireland Uc

    U.S.A
    arrow
    OTS 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Sofosbuvir Velpatasvir

    Brand Name : Epclusa

    Dosage Form : Film Coated Tablet

    Dosage Strength : 200mg;50mg

    Packaging :

    Approval Date : 25/08/2020

    Application Number : 20191015000117

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Gilead Sciences Ireland Uc

    U.S.A
    OTS 2025
    Not Confirmed
    arrow

    Gilead Sciences Ireland Uc

    U.S.A
    arrow
    OTS 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Sofosbuvir Velpatasvir

    Brand Name : Epclusa

    Dosage Form : Film Coated Tablet

    Dosage Strength : 400mg;100mg

    Packaging :

    Approval Date : 06/07/2016

    Application Number : 20151118000025

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Gilead Sciences Switzerland S?rl

    U.S.A
    OTS 2025
    Not Confirmed
    arrow

    Gilead Sciences Switzerland S?rl

    U.S.A
    arrow
    OTS 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Sofosbuvir|Velpatasvir

    Brand Name : Epclusa

    Dosage Form : Film Coated Tablet

    Dosage Strength : 400mg;100mg

    Packaging :

    Approval Date : 22/09/2016

    Application Number : 66095

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF